Tobam elevated its stake in shares of Cencora, Inc. (NYSE:COR – Free Report) by 85.7% in the course of the third quarter, in accordance with the corporate in its most up-to-date disclosure with the SEC. The institutional investor owned 25,030 shares of the corporate’s inventory after shopping for an extra 11,549 shares in the course of the quarter. Tobam’s holdings in Cencora have been price $5,634,000 on the finish of the newest reporting interval.
Different institutional buyers have additionally just lately added to or lowered their stakes within the firm. Rise Advisors LLC bought a brand new place in Cencora in the course of the first quarter price roughly $25,000. New Millennium Group LLC bought a brand new place in Cencora in the course of the second quarter price roughly $26,000. TCTC Holdings LLC bought a brand new place in Cencora in the course of the first quarter price roughly $29,000. TFO Wealth Companions LLC bought a brand new place in Cencora in the course of the first quarter price roughly $30,000. Lastly, LRI Investments LLC bought a brand new stake in Cencora within the first quarter valued at $31,000. Hedge funds and different institutional buyers personal 97.52% of the corporate’s inventory.
Insider Shopping for and Promoting
In different Cencora information, EVP Silvana Battaglia bought 1,473 shares of Cencora inventory in a transaction dated Tuesday, August sixth. The inventory was bought at a median value of $242.69, for a complete transaction of $357,482.37. Following the completion of the sale, the manager vice chairman now straight owns 10,948 shares of the corporate’s inventory, valued at $2,656,970.12. The commerce was a 0.00 % lower of their place. The sale was disclosed in a submitting with the Securities & Trade Fee, which is accessible at this hyperlink. In different Cencora information, CEO Steven H. Collis bought 10,755 shares of Cencora inventory in a transaction dated Tuesday, July sixteenth. The inventory was bought at a median value of $222.12, for a complete transaction of $2,388,900.60. Following the completion of the sale, the chief govt officer now straight owns 285,088 shares of the corporate’s inventory, valued at $63,323,746.56. The commerce was a 0.00 % lower of their place. The sale was disclosed in a submitting with the Securities & Trade Fee, which is accessible at this hyperlink. Additionally, EVP Silvana Battaglia bought 1,473 shares of the enterprise’s inventory in a transaction dated Tuesday, August sixth. The shares have been bought at a median value of $242.69, for a complete worth of $357,482.37. Following the completion of the sale, the manager vice chairman now straight owns 10,948 shares of the corporate’s inventory, valued at $2,656,970.12. The commerce was a 0.00 % lower of their possession of the inventory. The disclosure for this sale could be discovered right here. Insiders bought 4,450,399 shares of firm inventory valued at $1,070,392,799 within the final three months. 15.80% of the inventory is owned by company insiders.
Cencora Inventory Up 0.4 %
COR traded up $0.94 on Thursday, hitting $222.10. 416,869 shares of the corporate have been exchanged, in comparison with its common quantity of 1,410,904. Cencora, Inc. has a twelve month low of $182.75 and a twelve month excessive of $247.66. The corporate has a market cap of $44.30 billion, a price-to-earnings ratio of 24.20, a price-to-earnings-growth ratio of 1.58 and a beta of 0.44. The corporate has a present ratio of 0.89, a fast ratio of 0.55 and a debt-to-equity ratio of three.93. The agency has a 50-day transferring common value of $233.91 and a two-hundred day transferring common value of $231.68.
Cencora (NYSE:COR – Get Free Report) final launched its earnings outcomes on Wednesday, July thirty first. The corporate reported $3.34 EPS for the quarter, topping the consensus estimate of $3.18 by $0.16. Cencora had a return on fairness of 266.60% and a web margin of 0.65%. The agency had income of $74.20 billion in the course of the quarter, in comparison with analysts’ expectations of $73.32 billion. Throughout the identical interval within the earlier yr, the agency posted $2.92 EPS. Cencora’s income for the quarter was up 10.8% on a year-over-year foundation. On common, equities analysts predict that Cencora, Inc. will put up 13.63 earnings per share for the present yr.
Cencora Pronounces Dividend
The enterprise additionally just lately introduced a quarterly dividend, which was paid on Monday, August twenty sixth. Buyers of file on Friday, August ninth have been paid a dividend of $0.51 per share. The ex-dividend date of this dividend was Friday, August ninth. This represents a $2.04 annualized dividend and a yield of 0.92%. Cencora’s payout ratio is 22.32%.
Analyst Scores Adjustments
COR has been the subject of numerous analysis analyst reviews. Leerink Companions lowered their goal value on Cencora from $277.00 to $275.00 and set an “outperform” ranking on the inventory in a analysis report on Monday. Evercore ISI lowered their goal value on Cencora from $270.00 to $250.00 and set an “outperform” ranking on the inventory in a analysis report on Tuesday. Financial institution of America restated a “impartial” ranking and issued a $245.00 goal value (down beforehand from $275.00) on shares of Cencora in a analysis report on Wednesday, September 18th. Wells Fargo & Firm lifted their value goal on Cencora from $236.00 to $249.00 and gave the corporate an “equal weight” ranking in a analysis notice on Thursday, August 1st. Lastly, Robert W. Baird dropped their value goal on Cencora from $287.00 to $283.00 and set an “outperform” ranking for the corporate in a analysis notice on Friday, September sixth. Three equities analysis analysts have rated the inventory with a maintain ranking and eight have assigned a purchase ranking to the corporate. Primarily based on information from MarketBeat.com, the inventory presently has a median ranking of “Average Purchase” and a median value goal of $259.44.
Get Our Newest Report on Cencora
About Cencora
Cencora, Inc sources and distributes pharmaceutical merchandise. The corporate’s U.S. Healthcare Options section distributes prescribed drugs, over-the-counter healthcare merchandise, dwelling healthcare provides and tools, and associated companies to acute care hospitals and well being techniques, unbiased and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate web site pharmacies, and different prospects; supplies pharmacy administration, staffing, and different consulting companies; provide administration software program to retail and institutional healthcare suppliers; packaging options to varied institutional and retail healthcare suppliers; medical trial assist, product post-approval, and commercialization assist companies; information analytics, outcomes analysis, and extra companies for biotechnology and pharmaceutical producers; prescribed drugs, vaccines, parasiticides, diagnostics, micro feed components, and different merchandise to the companion animal and manufacturing animal markets; and gross sales power companies to producers.
See Additionally
Wish to see what different hedge funds are holding COR? Go to HoldingsChannel.com to get the newest 13F filings and insider trades for Cencora, Inc. (NYSE:COR – Free Report).
Obtain Information & Scores for Cencora Each day – Enter your e mail deal with beneath to obtain a concise each day abstract of the newest information and analysts’ scores for Cencora and associated firms with MarketBeat.com’s FREE each day e mail e-newsletter.
